These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 21688612

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS, Brajachand N, Singh HL, Singh YM.
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Mar; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 4. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
    Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK.
    J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
    [Abstract] [Full Text] [Related]

  • 5. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
    Fuglsang T, Fouchard JR, Ege PP.
    Ugeskr Laeger; 2000 Jul 03; 162(27):3860-4. PubMed ID: 10920701
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T, Ahmed T, Iqbal A, Islam M, Islam MN.
    J Health Popul Nutr; 2000 Dec 03; 18(3):145-50. PubMed ID: 11262767
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I.
    AIDS; 1996 Mar 03; 10(3):311-7. PubMed ID: 8882671
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B, Narayanan S, Navaratnam V.
    Drug Alcohol Rev; 2009 Jul 03; 28(4):447-54. PubMed ID: 19594801
    [Abstract] [Full Text] [Related]

  • 17. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
    Imani R, Karimi A, Rouzbahani R, Rouzbahani A.
    East Mediterr Health J; 2008 Jul 03; 14(5):1136-41. PubMed ID: 19161086
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B and C infection among drug abusers in Nepal.
    Shrestha SM, Shrestha DM, Gafney TE, Maharjan KG, Tsuda F, Okamoto H.
    Trop Gastroenterol; 1996 Jul 03; 17(4):212-3. PubMed ID: 9094859
    [Abstract] [Full Text] [Related]

  • 19. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S, Singh S.
    BMC Infect Dis; 2010 Mar 07; 10():53. PubMed ID: 20205948
    [Abstract] [Full Text] [Related]

  • 20. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S, Schieffer M, Jürgens S, Wehner HD, Flehmig B.
    Ig Sanita Pubbl; 2005 Mar 07; 61(5):435-50. PubMed ID: 17214028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.